NCT04965792View on ClinicalTrials.gov

Post-treatment Surveillance in HPV+ Oropharyngeal SCC

Active, not recruitingOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

November 19, 2020

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2027

Conditions

HPVOropharyngeal Squamous Cell Carcinoma

Interventions

OTHER

Screening

Blood test

Trial Locations (1)

02215

Dana Farber Cancer Institute, Boston

All Listed Sponsors

lead

Dana-Farber Cancer Institute

OTHER